How quickly does aspirin reduce heart attack risk?
Low-dose aspirin (typically 81-325 mg daily) starts providing cardiovascular protection within hours of the first dose. It irreversibly inhibits platelet aggregation by blocking cyclooxygenase-1 (COX-1), reducing thromboxane A2 production and halting platelet clumping that leads to clots. This antiplatelet effect peaks at 60 minutes and lasts 7-10 days due to aspirin's long duration of action on platelets.[1][2]
When do benefits show up in clinical studies?
In acute settings like suspected heart attack, immediate chewing of 162-325 mg aspirin cuts mortality risk by 23% within 24 hours, as shown in the Second International Study of Infarct Survival (ISIS-2) trial with over 17,000 patients.[3] For primary prevention (healthy people at risk), benefits like 12-20% reduction in nonfatal heart attacks emerge after 1-2 years of daily use, per meta-analyses of trials like Physicians' Health Study.[4][5]
Does it work right away for stroke prevention?
Yes for ischemic stroke risk during acute events—benefits begin within 30-60 minutes, similar to heart attack. Long-term secondary prevention after stroke or TIA shows risk reduction stabilizing after 3-6 months.[2][6]
Factors affecting onset time
- Dose and form: Enteric-coated delays absorption by 1-3 hours vs. immediate-release.[1]
- Patient variables: Faster in those without GI issues; smoking or high inflammation may blunt effects slightly.[7]
- Compliance: Missing doses resets protection since new platelets form daily (10% turnover).[2]
Risks before benefits kick in
Bleeding risk (GI or intracranial) rises immediately—2-4x higher than placebo in first weeks—outweighing benefits in low-risk people under age 60, per USPSTF guidelines. Net benefit for primary prevention often takes years to materialize.[5][8]
Sources
[1]: NEJM: Aspirin Effects on Platelets
[2]: AHA Guidelines on Antiplatelet Therapy
[3]: ISIS-2 Trial (Lancet)
[4]: USPSTF Aspirin Recommendation
[5]: Antithrombotic Trialists' Collaboration Meta-Analysis
[6]: AHA Stroke Guidelines
[7]: Pharmacology Review (Circulation)
[8]: FDA Aspirin Labeling